Clinical trial
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating…
NCT00002515 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002515 |
|---|---|
| Title | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer |
| Official title | Myeloablative Chemotherapy With Bone Marrow Rescue For Rare Poor-Prognosis Cancers |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lymphoma, Neuroblastoma, Ovarian Cancer, Retinoblastoma, Sarcoma and 1 more |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, carboplatin, thiotepa, topotecan hydrochloride, autologous bone marrow transplantation, bone marrow ablation with stem cell support, in vitro-treated bone marrow transplantation |
| Start date | Oct 1, 1992 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: